Report Detail
Global Opioids Agonist Drugs Market Insights, Forecast to 2025
- RnM2700490 |
- 14 June, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
The global Opioids Agonist Drugs market is valued at 18600 million US$ in 2018 and will reach 25900 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Opioids Agonist Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Opioids Agonist Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioids Agonist Drugs in these regions.
This research report categorizes the global Opioids Agonist Drugs market by top players/brands, region, type and end user. This report also studies the global Opioids Agonist Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Market size by Product
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Market size by End User
Pain Management
Cough Treatment
Diarrhea Treatment
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Opioids Agonist Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Opioids Agonist Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Opioids Agonist Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Opioids Agonist Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Opioids Agonist Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioids Agonist Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Opioids Agonist Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Opioids Agonist Drugs Market Size Growth Rate by Product
- 1.4.2 Codeine
- 1.4.3 Fentanyl
- 1.4.4 Meperidine
- 1.4.5 Methadone
- 1.4.6 Morphine
- 1.4.7 Hydrocodone
- 1.5 Market by End User
- 1.5.1 Global Opioids Agonist Drugs Market Size Growth Rate by End User
- 1.5.2 Pain Management
- 1.5.3 Cough Treatment
- 1.5.4 Diarrhea Treatment
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Opioids Agonist Drugs Market Size
- 2.1.1 Global Opioids Agonist Drugs Revenue 2014-2025
- 2.1.2 Global Opioids Agonist Drugs Sales 2014-2025
- 2.2 Opioids Agonist Drugs Growth Rate by Regions
- 2.2.1 Global Opioids Agonist Drugs Sales by Regions
- 2.2.2 Global Opioids Agonist Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Opioids Agonist Drugs Sales by Manufacturers
- 3.1.1 Opioids Agonist Drugs Sales by Manufacturers
- 3.1.2 Opioids Agonist Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Opioids Agonist Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Opioids Agonist Drugs Revenue by Manufacturers
- 3.2.1 Opioids Agonist Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Opioids Agonist Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Opioids Agonist Drugs Price by Manufacturers
- 3.4 Opioids Agonist Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Opioids Agonist Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Opioids Agonist Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Opioids Agonist Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Opioids Agonist Drugs Sales by Product
- 4.2 Global Opioids Agonist Drugs Revenue by Product
- 4.3 Opioids Agonist Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Opioids Agonist Drugs Breakdown Data by End User
6 North America
- 6.1 North America Opioids Agonist Drugs by Countries
- 6.1.1 North America Opioids Agonist Drugs Sales by Countries
- 6.1.2 North America Opioids Agonist Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Opioids Agonist Drugs by Product
- 6.3 North America Opioids Agonist Drugs by End User
7 Europe
- 7.1 Europe Opioids Agonist Drugs by Countries
- 7.1.1 Europe Opioids Agonist Drugs Sales by Countries
- 7.1.2 Europe Opioids Agonist Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Opioids Agonist Drugs by Product
- 7.3 Europe Opioids Agonist Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Opioids Agonist Drugs by Countries
- 8.1.1 Asia Pacific Opioids Agonist Drugs Sales by Countries
- 8.1.2 Asia Pacific Opioids Agonist Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Opioids Agonist Drugs by Product
- 8.3 Asia Pacific Opioids Agonist Drugs by End User
9 Central & South America
- 9.1 Central & South America Opioids Agonist Drugs by Countries
- 9.1.1 Central & South America Opioids Agonist Drugs Sales by Countries
- 9.1.2 Central & South America Opioids Agonist Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Opioids Agonist Drugs by Product
- 9.3 Central & South America Opioids Agonist Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Opioids Agonist Drugs by Countries
- 10.1.1 Middle East and Africa Opioids Agonist Drugs Sales by Countries
- 10.1.2 Middle East and Africa Opioids Agonist Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Opioids Agonist Drugs by Product
- 10.3 Middle East and Africa Opioids Agonist Drugs by End User
11 Company Profiles
- 11.1 Purdue Pharma
- 11.1.1 Purdue Pharma Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Purdue Pharma Opioids Agonist Drugs Products Offered
- 11.1.5 Purdue Pharma Recent Development
- 11.2 Titan pharmaceuticals
- 11.2.1 Titan pharmaceuticals Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Titan pharmaceuticals Opioids Agonist Drugs Products Offered
- 11.2.5 Titan pharmaceuticals Recent Development
- 11.3 Boehringer Ingelheim
- 11.3.1 Boehringer Ingelheim Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Boehringer Ingelheim Opioids Agonist Drugs Products Offered
- 11.3.5 Boehringer Ingelheim Recent Development
- 11.4 Janssen Pharmaceuticals, Inc
- 11.4.1 Janssen Pharmaceuticals, Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Products Offered
- 11.4.5 Janssen Pharmaceuticals, Inc Recent Development
- 11.5 Sanofi
- 11.5.1 Sanofi Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sanofi Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sanofi Opioids Agonist Drugs Products Offered
- 11.5.5 Sanofi Recent Development
- 11.6 Sun Pharmaceuticals
- 11.6.1 Sun Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Products Offered
- 11.6.5 Sun Pharmaceuticals Recent Development
- 11.7 Mallinckrodt Pharmaceuticals
- 11.7.1 Mallinckrodt Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Products Offered
- 11.7.5 Mallinckrodt Pharmaceuticals Recent Development
- 11.8 Egalet Corporation
- 11.8.1 Egalet Corporation Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Egalet Corporation Opioids Agonist Drugs Products Offered
- 11.8.5 Egalet Corporation Recent Development
- 11.9 Endo Pharmaceuticals Inc.
- 11.9.1 Endo Pharmaceuticals Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Products Offered
- 11.9.5 Endo Pharmaceuticals Inc. Recent Development
- 11.10 Allergan, Plc
- 11.10.1 Allergan, Plc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Allergan, Plc Opioids Agonist Drugs Products Offered
- 11.10.5 Allergan, Plc Recent Development
- 11.11 Pfizer Inc
12 Future Forecast
- 12.1 Opioids Agonist Drugs Market Forecast by Regions
- 12.1.1 Global Opioids Agonist Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Opioids Agonist Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Opioids Agonist Drugs Market Forecast by Product
- 12.2.1 Global Opioids Agonist Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Opioids Agonist Drugs Revenue Forecast by Product 2019-2025
- 12.3 Opioids Agonist Drugs Market Forecast by End User
- 12.4 North America Opioids Agonist Drugs Forecast
- 12.5 Europe Opioids Agonist Drugs Forecast
- 12.6 Asia Pacific Opioids Agonist Drugs Forecast
- 12.7 Central & South America Opioids Agonist Drugs Forecast
- 12.8 Middle East and Africa Opioids Agonist Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Opioids Agonist Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Opioids Agonist Drugs . Industry analysis & Market Report on Opioids Agonist Drugs is a syndicated market report, published as Global Opioids Agonist Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Opioids Agonist Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
